Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.

MLA

Fernández-Santos, Maria Eugenia, et al. “Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.” Frontiers in Immunology, vol. 13, June 2022, pp. 1–19. EBSCOhost, https://doi.org/10.3389/fimmu.2022.918565.

APA

Fernández-Santos, M. E., Garcia-Arranz, M., Andreu, E. J., García-Hernández, A. M., López-Parra, M., Villarón, E., Sepúlveda, P., Fernández-Avilés, F., García-Olmo, D., Prosper, F., Sánchez-Guijo, F., Moraleda, J. M., & Zapata, A. G. (2022). Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome. Frontiers in Immunology, 13, 1–19. https://doi.org/10.3389/fimmu.2022.918565

Chicago

Fernández-Santos, Maria Eugenia, Mariano Garcia-Arranz, Enrique J. Andreu, Ana Maria García-Hernández, Miriam López-Parra, Eva Villarón, Pilar Sepúlveda, et al. 2022. “Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.” Frontiers in Immunology 13 (June): 1–19. doi:10.3389/fimmu.2022.918565.